Sign In
Buy VERX
$12.98
+0.600 (+4.85%)
At Close: Jul 13, 2026
Final Trades: Vertex Pharma, Palantir, Wynn Resorts and Microsoft
01:38pm, Friday, 09'th May 2025
The Investment Committee give you their top names to watch for the second half.
Vertex to Present at 20th Annual Needham Technology, Media, & Consumer Conference
06:45pm, Thursday, 08'th May 2025
KING OF PRUSSIA, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a global provider of tax technology solutions, today announced that David DeStefano, Chief Executive Officer, and Joh
Vertex, Inc. (VERX) Q1 2025 Earnings Call Transcript
11:41pm, Wednesday, 07'th May 2025
Vertex, Inc. (NASDAQ:VERX ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Joe Crivelli - Vice President of Investor Relations David DeStefano - President and Chief Execu
Compared to Estimates, Vertex (VERX) Q1 Earnings: A Look at Key Metrics
10:36am, Wednesday, 07'th May 2025
The headline numbers for Vertex (VERX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Vertex (VERX) Q1 Earnings and Revenues Top Estimates
09:25am, Wednesday, 07'th May 2025
Vertex (VERX) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.15 per share a year ago.
Vertex Announces First Quarter 2025 Financial Results
07:05am, Wednesday, 07'th May 2025
KING OF PRUSSIA, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial r
Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip
04:49am, Wednesday, 07'th May 2025
Vertex Pharmaceuticals' (VRTX -9.39%) remarkable momentum came to a screeching halt this week. The big biotech stock had been up well over 20% year to date.
Vertex On Track To Significantly Improve Revenue And Earnings By 2030
10:12pm, Tuesday, 06'th May 2025
Vertex Pharmaceuticals reported decent Q1 earnings, but the company missed estimates for both revenue and earnings. Vertex's diversification efforts are most visible in the progress of its pain manage
Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?
04:28pm, Tuesday, 06'th May 2025
On Monday, Vertex Pharmaceuticals Incorporated VRTX reported lower-than-expected first-quarter 2025 earnings.
Vertex Pharmaceuticals Stock Is Tumbling After Earnings. Here's Why.
12:31pm, Tuesday, 06'th May 2025
The company discloses narrower-than-expected access to its new painkiller.
Top Stock Movers Now: Vertex, DoorDash, Constellation Energy, and More
12:06pm, Tuesday, 06'th May 2025
U.S. equities were lower at midday as the market watched for any possible deals involving Trump administration tariffs and awaited tomorrow's statement from the Federal Reserve policymakers following
Why Vertex Pharmaceuticals Stock Is Sinking Today
10:36am, Tuesday, 06'th May 2025
Shares of Vertex Pharmaceuticals (VRTX -11.69%) were sinking 11.9% as of 10:18 a.m. ET on Tuesday.
Rising Costs Weigh on Vertex Q1 Earnings
09:11am, Tuesday, 06'th May 2025
Here's our initial take on Vertex Pharmaceuticals' (VRTX -0.27%) first-quarter financial report.
Vertex: Improved Outlook Despite First Quarter Miss (Rating Upgrade)
08:04am, Tuesday, 06'th May 2025
Vertex Pharmaceuticals missed Q1 revenue and EPS estimates but this is not a cause for concern as the full-year outlook has improved. Alyftrek is off to a good start and early launch metrics of Journa
Vertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drug
04:18pm, Monday, 05'th May 2025
Vertex Pharmaceuticals missed Wall Street estimates for quarterly results on Monday, due to lower-than-expected sales of its cystic fibrosis (CF) drug Trikafta.
